BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 17337285)

  • 1. Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice.
    McNeal MM; Basu M; Bean JA; Clements JD; Choi AH; Ward RL
    Virology; 2007 Jul; 363(2):410-8. PubMed ID: 17337285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice.
    Choi AH; Basu M; McNeal MM; Bean JA; Clements JD; Ward RL
    Protein Expr Purif; 2004 Dec; 38(2):205-16. PubMed ID: 15555936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma is the only anti-rotavirus cytokine found after in vitro stimulation of memory CD4+ T cells from mice immunized with a chimeric VP6 protein.
    McNeal MM; Stone SC; Basu M; Clements JD; Choi AH; Ward RL
    Viral Immunol; 2007 Dec; 20(4):571-84. PubMed ID: 18158731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G).
    Smiley KL; McNeal MM; Basu M; Choi AH; Clements JD; Ward RL
    J Virol; 2007 Apr; 81(8):3740-8. PubMed ID: 17251301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
    García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
    Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.
    Choi AH; McNeal MM; Basu M; Flint JA; Stone SC; Clements JD; Bean JA; Poe SA; VanCott JL; Ward RL
    Vaccine; 2002 Sep; 20(27-28):3310-21. PubMed ID: 12213401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.
    McNeal MM; Stone SC; Basu M; Bean JA; Clements JD; Hendrickson BA; Choi AH; Ward RL
    Virology; 2006 Mar; 346(2):338-47. PubMed ID: 16375942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VP6: A candidate rotavirus vaccine.
    Ward RL; McNeal MM
    J Infect Dis; 2010 Sep; 202 Suppl():S101-7. PubMed ID: 20684688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.
    Dennehy M; Bourn W; Steele D; Williamson AL
    Vaccine; 2007 May; 25(18):3646-57. PubMed ID: 17339069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
    Choi AH; Knowlton DR; McNeal MM; Ward RL
    Virology; 1997 May; 232(1):129-38. PubMed ID: 9185596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
    Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).
    McNeal MM; VanCott JL; Choi AH; Basu M; Flint JA; Stone SC; Clements JD; Ward RL
    J Virol; 2002 Jan; 76(2):560-8. PubMed ID: 11752147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.
    VanCott JL; Prada AE; McNeal MM; Stone SC; Basu M; Huffer B; Smiley KL; Shao M; Bean JA; Clements JD; Choi AH; Ward RL
    J Virol; 2006 May; 80(10):4949-61. PubMed ID: 16641286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal delivery.
    Soler E; Parez N; Passet B; Dubuquoy C; Riffault S; Pillot M; Houdebine LM; Schwartz-Cornil I
    Vaccine; 2007 Aug; 25(34):6373-80. PubMed ID: 17629366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus-specific cytotoxic T lymphocytes recognize overlapping epitopes in the amino-terminal region of the VP7 glycoprotein.
    Buesa J; Raga JV; Colomina J; de Souza CO; Muñoz C; Gil MT
    Virology; 1999 May; 257(2):424-37. PubMed ID: 10329553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particles.
    Ogier A; Franco MA; Charpilienne A; Cohen J; Pothier P; Kohli E
    Eur J Immunol; 2005 Jul; 35(7):2122-30. PubMed ID: 15948217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional mapping of protective epitopes within the rotavirus VP6 protein in mice belonging to different haplotypes.
    Choi AH; McNeal MM; Basu M; Bean JA; VanCott JL; Clements JD; Ward RL
    Vaccine; 2003 Jan; 21(7-8):761-7. PubMed ID: 12531356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of mice against rotavirus challenge following intradermal DNA immunization by Biojector needle-free injection.
    Choi AH; Smiley K; Basu M; McNeal MM; Shao M; Bean JA; Clements JD; Stout RR; Ward RL
    Vaccine; 2007 Apr; 25(16):3215-8. PubMed ID: 17280754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant.
    Choi AH; McNeal MM; Flint JA; Basu M; Lycke NY; Clements JD; Bean JA; Davis HL; McCluskie MJ; VanCott JL; Ward RL
    Vaccine; 2002 Mar; 20(13-14):1733-40. PubMed ID: 11906760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.